EnterNext supports Europabio's event on the benefits of Biotechnology


Brussels– 23 June 2015– As a major financing centre for biotechnology companies in Europe, EnterNext, the Euronext subsidiary designed to promote and grow the market for small and mid cap companies,expressed its support to EuropaBio on the occasion of the organisation of its event on the Benefits of Biotechnology at the European Parliament. For years, EuropaBio has been representing the interests of industrial, healthcare and agrifood biotechnology with the different European institutions. This landmark EuropaBio event aims at giving a snapshot of the significance and importance of biotech today in relation to the grand challenges we face in Europe.

To celebrate the opening of EuropaBio’s Event on the Benefits of Biotechnology, Carlo Incerti, EuropaBio Chair and Philippe De Backer, Member of the European Parliament, were invited to ring the bell to open the trading on the European market of Euronext. They were joined by Vincent Van Dessel, CEO of Euronext Brussels and Alain Baetens, Head of Listings of Euronext Brussels.

Alain Baetens, Head of Listings of Euronext Brussels, stated: “The EuropaBio event puts the European biotechnology sector at the forefront of the real economy, underscoring its great value for health and the creation of jobs in Europe. The biotechnology sector also creates investment opportunities for retail and institutional investors, and access to financing for innovative entrepreneurs. Our EnterNext platform holds a leading position  in Europe in terms of IPOs for the biotechnology sector. Therefore, we strongly favour such federating initiatives, leveraged with the full support of the European institutions.”

Press Release Footer

About Euronext 
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With more than 1,900 listed issuers and around €6.5 trillion in market capitalisation as of end June 2023, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.  
For the latest news, follow us on Twitter (twitter.com/euronext) and LinkedIn (linkedin.com/euronext).

This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2023, Euronext N.V. - All rights reserved.